The MarCom Journal
SEE OTHER BRANDS

Your media and advertising news reporter

The MarCom Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The MarCom Journal.

Press releases published on May 31, 2025

Arvinas and Pfizer's Vepdegestrant Significantly Improves Progression-Free Survival for Patients with ESR1-Mutant, ER+/HER2- Advanced Breast Cancer

Arvinas and Pfizer's Vepdegestrant Significantly Improves Progression-Free Survival for Patients with ESR1-Mutant, ER+/HER2- Advanced Breast Cancer

Pivotal Phase 3 VERITAC-2 clinical trial results presented at ASCO demonstrate 2.9-month improvement in median progression-free survival when compared to fulvestrant in second line-plus patients with an estrogen receptor 1 mutation Vepdegestrant was …

Powering Innovation: Ufine Battery Joins The Battery Show Europe 2025

Powering Innovation: Ufine Battery Joins The Battery Show Europe 2025

Discover Ufine’s tailored lithium battery tech at The Battery Show Europe 2025. Join us at Booth 4-B41, Messe Stuttgart. GERMANY, May 31, 2025 /⁨EINPresswire.com⁩/ -- Ufine Battery, a premier custom lithium battery manufacturer based in China, is proud to …

The Good Feet Store Opens in Seabrook, NH to Help Local Residents and Workforce Live the Life They Love

The Good Feet Store Opens in Seabrook, NH to Help Local Residents and Workforce Live the Life They Love

The Leading Retailer of Premium, Personally-Fitted Arch Supports Expands with the Tenth Store in the Boston Area SEABROOK, NH, UNITED STATES, May 30, 2025 /⁨EINPresswire.com⁩/ -- The Good Feet Store, recognized nationally as the market-leading …

leagend Debuts Smart UPS Battery Management Solution to Strengthen Power Security for Financial Institutions

leagend Debuts Smart UPS Battery Management Solution to Strengthen Power Security for Financial Institutions

leagend SOLUTIONS, a global leader in battery monitoring and intelligent power management systems, has officially launched its UPS Battery Management Solution. SHENZHEN, GUANGDONG, CHINA, May 31, 2025 /⁨EINPresswire.com⁩/ -- In response to the growing …

Nurses for Natural Health Hosts Transformative Yoga Retreat for Nurses in France

Nurses for Natural Health Hosts Transformative Yoga Retreat for Nurses in France

PHOENIX , AZ, UNITED STATES, May 30, 2025 /⁨EINPresswire.com⁩/ -- This July, Nurses for Natural Health invites nurses from around the world to join a one-of-a-kind restorative yoga retreat in the picturesque town of Luz-Saint-Sauveur. Designed to blend …

National Vitiligo Bond Inc., Foundation and Community Partners Announce June 2025 Events to Celebrate Vitiligo Awareness

National Vitiligo Bond Inc., Foundation and Community Partners Announce June 2025 Events to Celebrate Vitiligo Awareness

ATLANTA, GA, UNITED STATES, May 30, 2025 /⁨EINPresswire.com⁩/ -- In honor of Vitiligo Awareness Month, the National Vitiligo Bond Inc Foundation (Vitiligo Bond) and its community partners are proud to announce a series of impactful events throughout June …

Late-breaking analysis demonstrates characteristics associated with long-term overall survival with Onivyde® regimen in metastatic pancreatic adenocarcinoma

Late-breaking analysis demonstrates characteristics associated with long-term overall survival with Onivyde® regimen in metastatic pancreatic adenocarcinoma

Phase III NAPOLI 3 trial is the largest and has the longest follow-up for an interventional study in metastatic pancreatic adenocarcinoma1 Post-hoc analysis of NAPOLI 3 study determined characteristics associated with long-term survival, with median …

Une analyse « Late Breaking » démontre les caractéristiques associées à la survie globale à long terme des patients avec un adénocarcinome pancréatique métastatique traités par Onivyde®

Une analyse « Late Breaking » démontre les caractéristiques associées à la survie globale à long terme des patients avec un adénocarcinome pancréatique métastatique traités par Onivyde®

L’essai de Phase III NAPOLI 3 est la plus grande étude interventionnelle réalisée à ce jour avec la plus longue période de suivi des patients avec un adénocarcinome pancréatique métastatique1. L’analyse post-hoc de l’étude NAPOLI 3 a permis de déterminer …

Immatics IMA203 PRAME Cell Therapy Data Presented at  2025 ASCO Annual Meeting Continues to Show Strong Anti-tumor Activity and Durability in Patients with Metastatic Melanoma

Immatics IMA203 PRAME Cell Therapy Data Presented at 2025 ASCO Annual Meeting Continues to Show Strong Anti-tumor Activity and Durability in Patients with Metastatic Melanoma

Extended Phase 1b trial follow-up on IMA203 PRAME cell therapy in 33 heavily pretreated patients with metastatic melanoma demonstrates favorable tolerability and promising clinical activity with ongoing deep and durable objective responses up to >2.5 years …

ImPact Biotech Presents Interim Analysis from Phase 3 ENLIGHTED Study of Padeliporfin VTP in LG UTUC at ASCO 2025

ImPact Biotech Presents Interim Analysis from Phase 3 ENLIGHTED Study of Padeliporfin VTP in LG UTUC at ASCO 2025

– Complete response (CR) observed in 73% (27/37) of evaluable patients with low-grade upper tract urothelial cancer (UTUC) who completed the Induction Treatment Phase (ITP) – – Padeliporfin VTP treatment continues to be safe and well-tolerated, …

Harbinger Health Showcases Multi-Cancer Early Detection Performance in High-Risk Populations at ASCO 2025

Harbinger Health Showcases Multi-Cancer Early Detection Performance in High-Risk Populations at ASCO 2025

Reflex blood-based multi-cancer early detection (MCED) test demonstrated clinically meaningful per-cancer Positive Predictive Value (PPV) and early-stage sensitivity for multiple cancers with elevated incidence and mortality in a high-risk population Data …

Xilio Therapeutics Announces Updated Phase 2 Data for Vilastobart, a Tumor-Activated Anti-CTLA-4, in Combination with Atezolizumab in Patients with Metastatic Microsatellite Stable Colorectal Cancer

Xilio Therapeutics Announces Updated Phase 2 Data for Vilastobart, a Tumor-Activated Anti-CTLA-4, in Combination with Atezolizumab in Patients with Metastatic Microsatellite Stable Colorectal Cancer

26% preliminary objective response rate observed in heavily pre-treated patients with metastatic microsatellite stable colorectal cancer (MSS CRC) without liver metastases Deep and durable responses ongoing for up to 37 weeks through the data cutoff, …

Maryland Student Wins NFTE Capital Youth Entrepreneurship Challenge

Maryland Student Wins NFTE Capital Youth Entrepreneurship Challenge

Washington, DC, May 31, 2025 (GLOBE NEWSWIRE) -- Global entrepreneurship education nonprofit Network for Teaching Entrepreneurship (NFTE) has named four local student businesses as the winners of its annual Capital Regional Youth Entrepreneurship Challenge …

OGN CLASS NOTICE: Organon & Co. Investors may have been Affected by Fraud – Contact BFA Law before July 22 Court Deadline (NYSE:OGN)

OGN CLASS NOTICE: Organon & Co. Investors may have been Affected by Fraud – Contact BFA Law before July 22 Court Deadline (NYSE:OGN)

NEW YORK, May 31, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti …

IOVA CLASS NOTICE: Iovance Biotherapeutics, Inc. Investors may have been Affected by Fraud – Contact BFA Law before July 14 Court Deadline (NASDAQ:IOVA)

IOVA CLASS NOTICE: Iovance Biotherapeutics, Inc. Investors may have been Affected by Fraud – Contact BFA Law before July 14 Court Deadline (NASDAQ:IOVA)

NEW YORK, May 31, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti …

CODI CLASS NOTICE: Compass Diversified Holdings Investors may have been Affected by Fraud – Contact BFA Law before July 8 Court Deadline (NYSE:CODI)

CODI CLASS NOTICE: Compass Diversified Holdings Investors may have been Affected by Fraud – Contact BFA Law before July 8 Court Deadline (NYSE:CODI)

NEW YORK, May 31, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti …

VTRS CLASS NOTICE: Viatris Inc. Investors may have been Affected by Fraud – Contact BFA Law before June 3 Court Deadline (NASDAQ:VTRS)

VTRS CLASS NOTICE: Viatris Inc. Investors may have been Affected by Fraud – Contact BFA Law before June 3 Court Deadline (NASDAQ:VTRS)

NEW YORK, May 31, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti …

CIVI CLASS NOTICE: Civitas Resources, Inc. Investors may have been Affected by Fraud – Contact BFA Law before July 1 Court Deadline (NYSE:CIVI)

CIVI CLASS NOTICE: Civitas Resources, Inc. Investors may have been Affected by Fraud – Contact BFA Law before July 1 Court Deadline (NYSE:CIVI)

NEW YORK, May 31, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti …

BBAI CLASS NOTICE: BigBear.ai Holdings, Inc. Investors may have been Affected by Fraud – Contact BFA Law before June 10 Court Deadline (NYSE:BBAI)

BBAI CLASS NOTICE: BigBear.ai Holdings, Inc. Investors may have been Affected by Fraud – Contact BFA Law before June 10 Court Deadline (NYSE:BBAI)

NEW YORK, May 31, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti …

RDDT INVESTIGATION NOTICE: Reddit, Inc. is being Investigated for Securities Fraud – Contact BFA Law if You Suffered Losses (NYSE:RDDT)

RDDT INVESTIGATION NOTICE: Reddit, Inc. is being Investigated for Securities Fraud – Contact BFA Law if You Suffered Losses (NYSE:RDDT)

NEW YORK, May 31, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service